Drug Profile

HU 010

Alternative Names: HU010

Latest Information Update: 19 Dec 2015

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Huons
Developer Chungnam National University; College of Medicine Korea University; Dongguk University; Huons
Class
Mechanism of Action Adenosine A3 receptor agonists

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

17 Dec 2015 No development reported - Phase-II for Stroke in South Korea (unspecified route)
31 Dec 2011 Phase-II clinical trials in Stroke in South Korea (unspecified route) (Huons pipeline, December 2015)
31 Dec 2008 Preclinical trials in Stroke in South Korea (unspecified route)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com